Use of igf-1 and nt-3 in the treatment of x-linked adrenoleukodystrophy
Mastroeni, Roberto; Raoul, Cedric; Aebischer, Patrick; Bensadoun, Jean-Charles
2010

Abstract

The present invention is directed to new compositions uses thereof and related methods for the treatment of X- linked adrenoleukodystrophy.

Details

Title Use of igf-1 and nt-3 in the treatment of x-linked adrenoleukodystrophy
Author(s) Mastroeni, Roberto ; Raoul, Cedric ; Aebischer, Patrick ; Bensadoun, Jean-Charles
Date 2010
Keywords
Note Alternative title(s) : (fr) Utilisation de igf-1 et de nt-3 dans le traitement d'une adrénoleucodystrophie à liaison x
Other identifier(s) EPO Family ID: 42104387
Patent number(s) WO2010089706 (A1)
Laboratories LEN
TTO
Record Appears in Scientific production and competences > SV - School of Life Sciences > SV Archives > LEN - Neurodegenerative Studies Laboratory
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Record creation date 2015-09-22

Actions